Haley Wardrip, MD
Pain Medicine · Shawnee Mission, KSNPI 1912494410
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 47.3% of the total. Reporting peaked in 2023 at $8,849 and has fallen 88.4% since, to $1,026 in 2025.
Across 155 payments — averaging $88.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Boston Scientific$2K
- Nevro Corp.$2K
- Saluda Medical Americas, Inc.$734
- Nalu Medical, Inc.$366
- Medtronic$336
- plus $1K from 12 others
What the payments were for
- Speaking & faculty fees$1,31910%
- Travel & lodging$4,36132%
- Food & beverage$7,98458%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 74 | $6,461 |
| Boston Scientific | 21 | $2,413 |
| Nevro Corp. | 11 | $2,080 |
| Saluda Medical Americas, Inc. | 14 | $734 |
| Nalu Medical, Inc. | 5 | $366 |
| Medtronic | 5 | $336 |
| Globus Medical | 4 | $246 |
| Painteq LLC | 1 | $227 |
| SPR Therapeutics, Inc | 4 | $221 |
| Merz Pharmaceuticals, LLC | 1 | $125 |
| MML US, Inc. | 3 | $119 |
| Relievant Medsystems, Inc. | 1 | $114 |
| Averitas Pharma Inc. | 4 | $105 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Avanos Medical | 1 | $23 |
| Tersera Therapeutics LLC | 1 | $17 |
| Merck | 1 | $14 |
| Electronic Waveform Lab, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$4,937
- Omnia$1,319
- Superion Indirect Decompression System$765
- WaveWriter Alpha Prime 16$732
- GENERAL - THERAPIES$710
- Intracept$458
- Senza$456
- Nalu Neurostimulation System$269
- ETERNA$260
- PAINTEQ$227
- Evoke SCS$206
- SYNCHROMEDII$171
- SPRINT PNS System$140
- XEOMIN$125
- Evoke$118
- INTELLIS ADAPTIVESTIM$112
- ReActiv8$110
How this compares
$13,664 in reported general payments places this provider in the 75th percentile of 64 pain medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 15 | $174 |
| Meloxicam | 14 | $24 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Shawnee Mission
- Smith ManionShawnee Mission$55K
- Usman LatifKansas City$734K
- Dawood SayedKansas City$649K
- Andrea ChadwickKansas City$269K
- Mayank GuptaOverland Park$199K
- Brian GoentzelWichita$99K
- Brian KimOverland Park$61K
- Jeffrey FosterOverland Park$56K
- Ryan ZwickMerriam$32K
- Christopher LamKansas City$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.